Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boston Scientific Corporation
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
ViroMissile, Inc.
Eisai Inc.
Jonsson Comprehensive Cancer Center
SAPU NANO (US) LLC
Guerbet
University of Washington
Nantes University Hospital
AccSalus Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
UNICANCER
Teclison Ltd.
Institut Bergonié
Stanford University
Xencor, Inc.
Provectus Pharmaceuticals
AbbVie
INSYS Therapeutics Inc
Delcath Systems Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Adherex Technologies, Inc.